May 9, 2016 —St. Jude Medical announced presentation of the MultiPoint Pacing (MPP) Investigational device exemption ...
Cardiac Resynchronization Therapy Devices (CRT)
Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.
May 3, 2016 — Biotronik announced U.S. Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac ...
April 18, 2016 — St. Jude Medical Inc. announced the U.S. launch and first U.S. implants of the Quadra Assura MP cardiac ...
March 29, 2016 — St. Jude Medical Inc. announced CE Mark approval and launch of three new Quartet left ventricular (LV) ...
March 17, 2016 — Medtronic plc announced that it received CE (Conformité Européenne) Mark for the first and only cardiac ...
March 4, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Acuity X4 ...
February 25, 2016 — Biotronik announced that its Itrevia 7 HF-T cardiac resynchronization therapy defibrillator (CRT-D) ...
February 3, 2016 — Biotronik announced CE approval for its new Ilivia implantable cardioverter defibrillators (ICDs) and ...
December 14, 2015 — St. Jude Medical Inc. announced CE Mark approval for magnetic resonance (MR) conditional labeling ...
November 4, 2015 — LivaNova PLC, formerly Sorin Group, launched Platinum, a new range of implantable cardiac ...
October 30, 2015 — Boston Scientific Corp. has received CE Mark on magnetic resonance imaging (MRI) conditional labeling ...
September 3, 2015 — Sorin Group announced the start of patient enrollment in its TRIUMPH-CRT clinical trial in Europe.
...
September 3, 2015 — Most patients with a cardiac resynchronization therapy (CRT) pacemaker would not benefit from the ...
August 17, 2015 — Biotronik announced that the first patient has been enrolled in the BioCONTINUE clinical trial ...

July 28, 2015 — Biotronik announced the first patients have been successfully implanted with Itrevia HF-T QP cardiac ...